China Withdraws Licenses of 328 Medical Apparatus Manufacturers (China)
This article was originally published in PharmAsia News
Executive Summary
China's State Food and Drug Administration (SFDA) has announced the revocation of production licenses for 328 medical equipment firms. According to SFDA representatives, the regulator's actions are the result of "malpractice" on the part of the firms. The SFDA also revoked registration licenses for 65 pieces of medical equipment and canceled registrations for another 147 because of a failure to meet quality standards. So far, no specific examples of violations have been made public. (Click here for more - May Require Free Registration
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.